Hollings Cancer Center — Charleston, South Carolina

Public research footprint of Hollings Cancer Center, compiled from the ClinicalTrials.gov public registry.

331

Registered studies

Active

Recruiting now

206

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) · Platinum Resistant High Grade Epithelial Ovarian Cancer · Relapsed B-Cell Non-Hodgkin Lymphoma

Recently updated registry entries

NCT06191744 — Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral… (Active Not Recruiting)
NCT07650448 — WATER IV PCa (AS Sub-study) (Not Yet Recruiting)
NCT06084481 — Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hollings Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.